B-type Natriuretic Peptide Changes and Left Ventricular Remodeling Dynamics in Heart Failure with Reduced Ejection...

Area of Science:

• Cardiology
• Biomarkers
• Heart Failure Research

Background:

• B-type natriuretic peptide (BNP) is a key biomarker for heart failure with reduced ejection fraction (HFrEF).
• Understanding BNP dynamics is crucial for managing HFrEF and predicting outcomes.
• Long-term changes in BNP and their association with left ventricular (LV) geometry require further investigation.

Purpose of the Study:

• To explore the relationship between changes in BNP levels and long-term dynamics of LV geometry in HFrEF patients.
• To investigate the association between BNP change tertiles and LV remodeling parameters.
• To assess the impact of BNP changes on all-cause mortality in HFrEF.

Main Methods:

• Retrospective cohort study of 887 HFrEF patients with baseline and subsequent BNP measures.
• Patients categorized into tertiles based on percent BNP change: decreasing, minimal change, and rising.
• Primary endpoints included changes in LV internal dimensions (LVIDs, LVIDd) and LV ejection fraction (LVEF); secondary endpoint was all-cause mortality.

Main Results:

• Significant variations in baseline characteristics were observed across BNP change tertiles.
• Patients with decreasing BNP showed improved LV geometry, including reduced LVIDs and LVIDd, and increased LVEF compared to those with rising BNP.
• The rising BNP tertile exhibited a higher rate of all-cause mortality compared to the decreasing BNP tertile.

Conclusions:

• BNP changes demonstrate a time-dependent relationship with LV remodeling dynamics and survival in HFrEF.
• Findings support the utility of BNP as a dynamic marker reflecting LV remodeling processes.
• Monitoring BNP trends offers valuable insights into prognosis and guiding management strategies in HFrEF.